Please assess the completion status of the following clinical trial:

Trial Title: Using Saline for Myofascial Pain Syndromes (USAMPS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients diagnosed with MPS of the trapezius, gluteus medius/minimus, iliocostalis thoracis-lumborum, quadratus Lumborum, or paraspinal muscles in the emergency department.~Exclusion Criteria:~* Patients allergic to lidocaine and/or steroids.~* Pregnant women.~* Prisoners.~* Patients who are cognitively impaired and/or unable to consent for the study.~* Age \< 18.~* Signs of localized infection or skin breakdown at the injection site.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TPI with Normal Saline (Type: EXPERIMENTAL): Trigger point injection (TPI) with 1 mL of normal saline solution. Trigger point injection involves a single injection in the area of maximal tenderness or trigger point. This will be performed by the treating physician under sterile technique with a 25 gauge needle.
- TPI with Lidocaine & Triamcinolone Acetonide (Type: ACTIVE_COMPARATOR): Trigger point injection (TPI) with 1 mL of conventional drug mix (lidocaine 1%; 10 mL+ triamcinolone acetonide 40 mg/mL). Trigger point injection involves a single injection in the area of maximal tenderness or trigger point. This will be performed by the treating physician under sterile technique with a 25 gauge needle.

Based on this trial design, predict the completion outcome and termination type (if applicable).